Targeted therapy in SDH-deficient GIST

The medical management of advanced gastrointestinal stromal tumors (GIST) has improved with the development of tyrosine kinase inhibitors (TKIs) targeting KIT and PDGFRA mutations. However, approximately 5–10% of GIST lack KIT and PDGFRA mutations, and about a half are deficient in succinate dehydro...

Descripción completa

Detalles Bibliográficos
Autores principales: Nannini, Margherita, Rizzo, Alessandro, Indio, Valentina, Schipani, Angela, Astolfi, Annalisa, Pantaleo, Maria Abbondanza
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246492/
https://www.ncbi.nlm.nih.gov/pubmed/34262616
http://dx.doi.org/10.1177/17588359211023278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246492/
https://www.ncbi.nlm.nih.gov/pubmed/34262616
http://dx.doi.org/10.1177/17588359211023278

Ejemplares similares